NeuBase Therapeutics falls on 1-for-20 reverse stock split

NeuBase Therapeutics

14/06/2023 15:07

** Shares of biopharmaceutical company NeuBase Therapeutics
 NBSE.O  down 16.6% at $0.15
    ** Company announces reverse stock split at a ratio of
1-for-20
    ** NBSE's common stock to begin trading on reverse stock
split-adjusted basis upon market opening on June 15
    ** Reverse stock split is intended for the company to regain
compliance with minimum bid price requirement for continued
listing on Nasdaq
    ** Shares down 21.08% YTD
    

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))